First, the risk score model for each patient with GC was calculated and constructed based on the expression levels of DYNLL1, PLOD2, PHYHIP, HPR, PGK2, and CXCR4, in the GEO microarray data. This evidence concerns the gene PHYHIP and gastric cancer.